Lucence tests support cancer diagnosis, treatment selection, and disease monitoring for improved cancer care. Through identifying clinically-relevant mutations that are driving the growth of each patient’s unique cancer, physicians can better understand the disease for improved management. Additionally, Lucence blood tests can also identify patients who have inherited cancers for matching to appropriate targeted therapy and future risk management.